US 9296730
Aurora kinase inhibitors
granted A61KA61K31/4015A61P
Quick answer
US patent 9296730 (Aurora kinase inhibitors) held by Regents of the University of Minnesota expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4015, A61P, A61P35/00